BG24813A4 - Method of obtaining 2-tetrahydrofurfuryl-6,7-benzomorphanes and salts thereof - Google Patents

Method of obtaining 2-tetrahydrofurfuryl-6,7-benzomorphanes and salts thereof

Info

Publication number
BG24813A4
BG24813A4 BG7500030537A BG3053775A BG24813A4 BG 24813 A4 BG24813 A4 BG 24813A4 BG 7500030537 A BG7500030537 A BG 7500030537A BG 3053775 A BG3053775 A BG 3053775A BG 24813 A4 BG24813 A4 BG 24813A4
Authority
BG
Bulgaria
Prior art keywords
benzomorphanes
tetrahydrofurfuryl
salts
obtaining
Prior art date
Application number
BG7500030537A
Other languages
Bulgarian (bg)
English (en)
Inventor
Merz
Langbein
Walther
Stockhaus
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of BG24813A4 publication Critical patent/BG24813A4/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG7500030537A 1974-03-09 1975-03-07 Method of obtaining 2-tetrahydrofurfuryl-6,7-benzomorphanes and salts thereof BG24813A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2411382A DE2411382C3 (de) 1974-03-09 1974-03-09 2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung

Publications (1)

Publication Number Publication Date
BG24813A4 true BG24813A4 (en) 1978-05-12

Family

ID=5909593

Family Applications (3)

Application Number Title Priority Date Filing Date
BG7500030538A BG24814A4 (en) 1974-03-09 1975-03-07 Method of obtaining 2-tetrahydrofurfuryl-6,7-benzomorphanes and salts thereof
BG7500030537A BG24813A4 (en) 1974-03-09 1975-03-07 Method of obtaining 2-tetrahydrofurfuryl-6,7-benzomorphanes and salts thereof
BG7500029183A BG25087A3 (en) 1974-03-09 1975-03-07 A method of obtaining 2-tetrahydrofurfuryl-6,7-benzomorphanes and their salts

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG7500030538A BG24814A4 (en) 1974-03-09 1975-03-07 Method of obtaining 2-tetrahydrofurfuryl-6,7-benzomorphanes and salts thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG7500029183A BG25087A3 (en) 1974-03-09 1975-03-07 A method of obtaining 2-tetrahydrofurfuryl-6,7-benzomorphanes and their salts

Country Status (25)

Country Link
JP (1) JPS5827275B2 (fr)
AT (1) AT344332B (fr)
BE (1) BE826440A (fr)
BG (3) BG24814A4 (fr)
CA (1) CA1049511A (fr)
CH (8) CH612425A5 (fr)
CS (1) CS188221B2 (fr)
DD (1) DD119236A5 (fr)
DE (1) DE2411382C3 (fr)
DK (1) DK137188C (fr)
ES (6) ES440345A1 (fr)
FI (1) FI63571C (fr)
FR (1) FR2262984B1 (fr)
GB (1) GB1496418A (fr)
HU (1) HU177408B (fr)
IE (1) IE40945B1 (fr)
IL (1) IL46760A (fr)
NL (1) NL7502724A (fr)
NO (1) NO141800C (fr)
PH (1) PH14127A (fr)
PL (3) PL93699B1 (fr)
RO (2) RO70051A (fr)
SE (1) SE421919B (fr)
SU (3) SU577982A3 (fr)
ZA (1) ZA751394B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
JP3955093B2 (ja) * 1995-03-10 2007-08-08 フォトキュア エイエスエイ 光化学治療における光増感剤としての5−アミノレブリン酸のエステル
US6492420B2 (en) 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US7530461B2 (en) 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
US6723750B2 (en) 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
ATE554078T1 (de) 2007-07-26 2012-05-15 Vitae Pharmaceuticals Inc Synthese von 11-beta-hydroxysteroid-dehydrogenase-1-hemmern
CL2008003407A1 (es) 2007-11-16 2010-01-11 Boehringer Ingelheim Int Compuestos derivados de aril- y heteroarilcarbonilo de heterobiciclo sustituido; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de trastornos metabolicos, mediado por la inhibicion de la enzima hsd-1.
WO2009075835A1 (fr) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc Inhibiteurs cycliques d'urée de la 11-hydroxystéroïde déhydrogénase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
US8592409B2 (en) 2008-01-24 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5730021B2 (ja) 2008-02-15 2015-06-03 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤としてのシクロアルキルラクタム誘導体
EP2291370B1 (fr) 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déhydrogénase 1
AR071236A1 (es) 2008-05-01 2010-06-02 Vitae Pharmaceuticals Inc Inhibidores ciclicos de la 11beta-hidroxiesteroide deshidrogenasa 1
AR071609A1 (es) 2008-05-01 2010-06-30 Vitae Pharmaceuticals Inc Inhibidores ciclicos de 11(beta) -hidroxiesteroide deshidrogenasa 1
CL2009001151A1 (es) 2008-05-13 2010-08-13 Boehringer Ingelheim Int Compuestos derivados de acidos carbociclicos aliciclicos de benzomorfanos, procedimiento de preparacion, composicion farmaceutica, utiles para tratar enfermedades influenciadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa, como trastornos metabolicos.
WO2010010157A2 (fr) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibiteurs de la 11 bêta-hydroxystéroïde déshydrogénase 1
CA2730499A1 (fr) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibiteurs cycliques de la 11 beta-hydroxysteroide deshydrogenase 1
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
EP2440537A1 (fr) 2009-06-11 2012-04-18 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déshydrogénase 1 basée sur la structure 1,3-oxazinan-2-one
TWI531571B (zh) 2009-11-06 2016-05-01 維它藥物公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜芳基羰基衍生物
EP2582698B1 (fr) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Hétérocycles à 5, 6 et 7 chaînons substitués, médicaments contenant ces composés et leur utilisation
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
WO2013025664A1 (fr) 2011-08-17 2013-02-21 Boehringer Ingelheim International Gmbh Dérivés d'indénopyridine

Also Published As

Publication number Publication date
IE40945L (en) 1975-09-09
ES440346A1 (es) 1977-03-01
IE40945B1 (en) 1979-09-12
RO69617A (fr) 1980-08-15
FI63571B (fi) 1983-03-31
ES440348A1 (es) 1977-06-01
CH622016A5 (en) 1981-03-13
CH622015A5 (en) 1981-03-13
DD119236A5 (fr) 1976-04-12
AU7894275A (en) 1976-09-16
SU588916A3 (ru) 1978-01-15
IL46760A (en) 1978-12-17
ES440350A1 (es) 1977-03-16
NO750773L (fr) 1975-09-10
HU177408B (en) 1981-10-28
DK92975A (fr) 1975-09-10
DK137188B (da) 1978-01-30
CA1049511A (fr) 1979-02-27
PL93699B1 (fr) 1977-06-30
CS188221B2 (en) 1979-02-28
CH622014A5 (en) 1981-03-13
FR2262984A1 (fr) 1975-10-03
SU577983A3 (ru) 1977-10-25
IL46760A0 (en) 1975-05-22
CH612425A5 (en) 1979-07-31
PL93499B1 (fr) 1977-05-30
BG25087A3 (en) 1978-07-12
RO70051A (fr) 1980-12-30
DE2411382B2 (de) 1979-01-18
ES440347A1 (es) 1977-06-01
DK137188C (da) 1978-07-03
NO141800C (no) 1980-06-04
BG24814A4 (en) 1978-05-12
CH620681A5 (en) 1980-12-15
JPS5827275B2 (ja) 1983-06-08
AT344332B (de) 1978-07-10
CH620440A5 (en) 1980-11-28
NO141800B (no) 1980-02-04
FI63571C (fi) 1983-07-11
DE2411382C3 (de) 1979-09-06
ATA153875A (de) 1977-11-15
CH622017A5 (en) 1981-03-13
ZA751394B (en) 1976-11-24
BE826440A (fr) 1975-09-08
FR2262984B1 (fr) 1978-07-28
NL7502724A (nl) 1975-09-11
PL93700B1 (fr) 1977-06-30
SE7502592L (fr) 1975-09-10
ES440349A1 (es) 1977-03-01
SU577982A3 (ru) 1977-10-25
FI750652A (fr) 1975-09-10
JPS50123675A (fr) 1975-09-29
PH14127A (en) 1981-02-26
CH620439A5 (en) 1980-11-28
ES440345A1 (es) 1977-03-01
GB1496418A (en) 1977-12-30
SE421919B (sv) 1982-02-08
DE2411382A1 (de) 1975-09-18

Similar Documents

Publication Publication Date Title
BG24813A4 (en) Method of obtaining 2-tetrahydrofurfuryl-6,7-benzomorphanes and salts thereof
BG25088A3 (en) A method of obtaining 5,9-beta-substituted-2-tetrahydrofurfuryl-6,7-benzomorphanes and their salts
CS181182B2 (en) Vehiculum of medicament and method of its produce
BG27744A3 (en) Method of obtaining of hynazolin derivatives
BG24812A3 (en) Method of obtaining 8-thiomethylergolins
PH11250A (en) (-aryl-4)substituted piperidinoalkanol derivatives,composition and method of use thereof
BG24542A3 (en) Method of preparing carbonylaldiminomethanphosphonates
CS191882B2 (en) Method of preparing 7-methoxy-6-thia-tetracycline
BG28263A3 (en) Method of obtaining n- (phosphonomeometil) clycin
BG25221A3 (en) A method of obtaining 2,6-disubstituted-2-phenylimine-imidazolidines and their salts
BG24807A3 (en) Method of obtaining pyridobenzodiazepinones
BG27915A3 (en) Method of obtaining of moenomyzin
GR59201B (en) Preparation method of 8,8-disubstituted-6-methylergolines and related compounds
ZA75416B (en) Ureidotetralin compounds and method of use
CS188251B2 (en) Method of producing 4-oxo-4h-pyrano-3,2-c-qunolin-2-carboxylic acids and salts thereof
CS191954B2 (en) Method of preparing 3-acetoxy-3,7-dimethyl-6-octennitrile
JPS51118711A (en) Dividing method and compound
IL48565A0 (en) Method of preparation of 3-methylenecephams
GR58594B (en) Preparation method of 2-halogenmethyl-1,4,-benzodiazepine
BG24798A3 (en) Method of obtaining a-6-deoxytetracyclines
BG27376A3 (en) Method of obtaining of ureidesubstiputed cefalosporines
CS191953B2 (en) Method of preparing 3,7-dimethyl-3-hydroxy-6-octennitrile
BG28621A1 (en) Method of obtaining of phenol,alpha- methystyrene and cumol
YU72475A (en) Process for obtaining new basic enolethers and salts thereof
CS179935B2 (en) Method for producing 2-animomethylpyrrolidine and addition salts of the same